Anixa Biosciences, Inc.

Nasdaq: ANIX
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisors
  • Technologies
    • CAR-T
      • Introduction
      • Markets
      • Science
      • Collaborators
    • Cancer Vaccines
      • Introduction
      • Markets
      • Science
      • Collaborators
    • COVID-19
      • Introduction
      • Science
      • Collaborators
  • Pipeline
  • Investors
    • Overview
    • News Releases
    • Events & Presentations
      • Events
      • Corporate Presentation
    • Stock Information
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • SEC Filings
    • Financial Reports
      • Annual Reports
      • Quarterly Reports
    • Corporate Governance
      • Governance Documents
      • Committee Charters
  • News
    • Press Releases
    • Anixa In The News
    • Publications
  • Careers
  • Contact Us

News Releases

Investors

Investors

  • Overview
  • News Releases
  • Events & Presentations
    • Events
    • Corporate Presentation
  • Stock Info
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
  • Financial Reports
    • Annual Reports
    • Quarterly Reports
  • Governance
    • Governance Documents
    • Committee Charters
  • Investor Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR
    • RSS News Feed
  • All News
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015

Moffitt Cancer Center and ITUS Corporation Request Meeting with FDA Regarding Ovarian Cancer CAR-T Therapy

August 1, 2018

ITUS Corporation Releases Results for Cchek™ Breast Cancer Study

July 30, 2018

ITUS Corporation Announces Second Commercial Focus for Cchek™ will be Breast Cancer

July 6, 2018

ITUS to Ring the NASDAQ Closing Bell on July 5th

June 29, 2018

ITUS Accelerates Schedule for its CAR T Therapy and Provides Update

June 26, 2018

ITUS Corporation Announces First Commercial Focus for Cchek™ will be Prostate Cancer

June 13, 2018

ITUS Corporation to Present at the 3rd Annual Disruptive Growth & Healthcare Conference Hosted by RHK Capital and ReedSmith

May 1, 2018

ITUS Presentation to Special Meeting of Stockholders

April 2, 2018

ITUS and Serametrix Announce Results of a Blinded Prostate Cancer Study

March 27, 2018

ITUS Announces Issuance of Second Key Cancer Detection Technology Patent

March 26, 2018

RSS
  • « Previous
  • 1...
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • ...17
  • Next »

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

Mar 4, 2021

Anixa Biosciences Announces European Patent Issued for its CAR-T Cancer Therapy

Read More...
Feb 25, 2021

Anixa Biosciences to Present at the H.C. Wainwright Global Life Sciences Conference

Read More...
Feb 16, 2021

Anixa Biosciences Begins Animal Testing of Covid-19 Therapeutic Candidates

Read More...
Copyrights © 2021 Anixa Biosciences, Inc.. All Rights Reserved.
Privacy Policy Disclaimer Sitemap